Tofacitinib versus methotrexate in rheumatoid arthritis: patient-reported outcomes from the randomised phase III ORAL Start trial.
Vibeke StrandEun Bong LeeRoy FleischmannRieke E AltenTamas KonczSamuel H ZwillichDavid GrubenBethanie WilkinsonSriram KrishnaswamiGene WallensteinPublished in: RMD open (2016)
NCT01039688.